CALIFORNIA LEGISLATURE 20192020 REGULAR SESSION Senate Bill No. 525Introduced by Senator StoneFebruary 21, 2019 An act relating to Medi-Cal. LEGISLATIVE COUNSEL'S DIGESTSB 525, as introduced, Stone. Medi-Cal: benefits: blood factors.Existing law provides for the Medi-Cal program, which is administered by the State Department of Health Care Services, under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Existing law provides for a schedule of benefits covered by the Medi-Cal program, including the purchase of prescribed drugs subject to the Medi-Cal list of contract drugs and utilization controls. Existing law authorizes the department to enter into contracts with manufacturers of single source and multiple source drugs on a bid or nonbid basis, to maintain a list of contract drugs, such as blood factors, and to require pharmaceutical manufacturers to provide the department a state rebate, in addition to rebates pursuant to other provisions of state or federal law. Existing law provides for the reimbursement for blood factors, as specified.This bill would state the intent of the Legislature to enact legislation that protects access to blood factors and pharmacy services for Medi-Cal patients.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: NO Local Program: NO Bill TextThe people of the State of California do enact as follows:SECTION 1. It is the intent of the Legislature to enact legislation that protects patient access to blood factors and pharmacy services for individuals in the Medi-Cal program.
CALIFORNIA LEGISLATURE 20192020 REGULAR SESSION Senate Bill No. 525Introduced by Senator StoneFebruary 21, 2019 An act relating to Medi-Cal. LEGISLATIVE COUNSEL'S DIGESTSB 525, as introduced, Stone. Medi-Cal: benefits: blood factors.Existing law provides for the Medi-Cal program, which is administered by the State Department of Health Care Services, under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Existing law provides for a schedule of benefits covered by the Medi-Cal program, including the purchase of prescribed drugs subject to the Medi-Cal list of contract drugs and utilization controls. Existing law authorizes the department to enter into contracts with manufacturers of single source and multiple source drugs on a bid or nonbid basis, to maintain a list of contract drugs, such as blood factors, and to require pharmaceutical manufacturers to provide the department a state rebate, in addition to rebates pursuant to other provisions of state or federal law. Existing law provides for the reimbursement for blood factors, as specified.This bill would state the intent of the Legislature to enact legislation that protects access to blood factors and pharmacy services for Medi-Cal patients.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: NO Local Program: NO
CALIFORNIA LEGISLATURE 20192020 REGULAR SESSION
Senate Bill No. 525
Introduced by Senator StoneFebruary 21, 2019
Introduced by Senator Stone
February 21, 2019
An act relating to Medi-Cal.
LEGISLATIVE COUNSEL'S DIGEST
## LEGISLATIVE COUNSEL'S DIGEST
SB 525, as introduced, Stone. Medi-Cal: benefits: blood factors.
Existing law provides for the Medi-Cal program, which is administered by the State Department of Health Care Services, under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Existing law provides for a schedule of benefits covered by the Medi-Cal program, including the purchase of prescribed drugs subject to the Medi-Cal list of contract drugs and utilization controls. Existing law authorizes the department to enter into contracts with manufacturers of single source and multiple source drugs on a bid or nonbid basis, to maintain a list of contract drugs, such as blood factors, and to require pharmaceutical manufacturers to provide the department a state rebate, in addition to rebates pursuant to other provisions of state or federal law. Existing law provides for the reimbursement for blood factors, as specified.This bill would state the intent of the Legislature to enact legislation that protects access to blood factors and pharmacy services for Medi-Cal patients.
Existing law provides for the Medi-Cal program, which is administered by the State Department of Health Care Services, under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Existing law provides for a schedule of benefits covered by the Medi-Cal program, including the purchase of prescribed drugs subject to the Medi-Cal list of contract drugs and utilization controls. Existing law authorizes the department to enter into contracts with manufacturers of single source and multiple source drugs on a bid or nonbid basis, to maintain a list of contract drugs, such as blood factors, and to require pharmaceutical manufacturers to provide the department a state rebate, in addition to rebates pursuant to other provisions of state or federal law. Existing law provides for the reimbursement for blood factors, as specified.
This bill would state the intent of the Legislature to enact legislation that protects access to blood factors and pharmacy services for Medi-Cal patients.
## Digest Key
## Bill Text
The people of the State of California do enact as follows:SECTION 1. It is the intent of the Legislature to enact legislation that protects patient access to blood factors and pharmacy services for individuals in the Medi-Cal program.
The people of the State of California do enact as follows:
## The people of the State of California do enact as follows:
SECTION 1. It is the intent of the Legislature to enact legislation that protects patient access to blood factors and pharmacy services for individuals in the Medi-Cal program.
SECTION 1. It is the intent of the Legislature to enact legislation that protects patient access to blood factors and pharmacy services for individuals in the Medi-Cal program.
SECTION 1. It is the intent of the Legislature to enact legislation that protects patient access to blood factors and pharmacy services for individuals in the Medi-Cal program.
### SECTION 1.